| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Infranco Moore Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
First MCO is unique in the worker`s compensation industry in that it develops networks of specialists where the employers have the ability to direct care to them. With a rich 36-year company history, First MCO has grown into national experts in driving care for private and public sectors. The company works with insurance companies, self-insurers, third party administrators and insurance funds to provide comprehensive medical management and cost containment services for workers` compensation in New Jersey, Nevada, Missouri, Pennsylvania, Virginia, and Connecticut. The skilled medical team and professional staff at First MCO pride themselves on individualized customer service and convenient managed care solutions to get people back to work.
Advogent is a Wayne, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthLeaders-InterStudy is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.